MLN8054, an Inhibitor of Aurora a Kinase, Induces Senescence in Human Tumor Cells Both in Vitro and in Vivo

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-09-0300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Antitumor Activity of MLN8054, an Orally Active Small-Molecule Inhibitor of Aurora a Kinase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

GSK1070916, a Potent Aurora B/C Kinase Inhibitor With Broad Antitumor Activity in Tissue Culture Cells and Human Tumor Xenograft Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

miR-135a Contributes to Paclitaxel Resistance in Tumor Cells Both in Vitro and in Vivo

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-Tumor Ability in Human Cancer Cells in Vitro and in Vivo

Frontiers in Pharmacology
Pharmacology
2018English

A Single Starfish Aurora Kinase Performs the Combined Functions of Aurora-A and Aurora-B in Human Cells

Journal of Cell Science
Cell Biology
2010English

Oligosaccharyltransferase Inhibition Induces Senescence in RTK-driven Tumor Cells

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Tumor Necrosis Factor Increases the Production of Plasminogen Activator Inhibitor in Human Endothelial Cells in Vitro and in Rats in Vivo

1987English

Dictyostelium Aurora Kinase Has Properties of Both Aurora a and Aurora B Kinases

Eukaryotic Cell
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy